These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

871 related items for PubMed ID: 16078909

  • 1. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 2. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [Abstract] [Full Text] [Related]

  • 4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 5. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 6. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [Abstract] [Full Text] [Related]

  • 7. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 8. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [Abstract] [Full Text] [Related]

  • 10. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
    Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group.
    Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL, Notari EP, Krysztof DE, Dodd RY.
    Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

  • 14. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 16. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [Abstract] [Full Text] [Related]

  • 17. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 18. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT.
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [Abstract] [Full Text] [Related]

  • 19. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
    Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Japanese Red Cross NAT Screening Research Group.
    Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
    [Abstract] [Full Text] [Related]

  • 20. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group.
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.